These results indicate that anethole is an efficient inhibitor of several oral cancers related signaling pathways including MAPK/NF-κB and Wnt/β-catenin, leading to strong inhibition of cyclin D1. Here, NFKB1 is linked to lip and oral cavity carcinoma.